Literature DB >> 9326914

Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas.

A O Vortmeyer1, I A Lubensky, M J Merino, C Y Wang, T Pham, E E Furth, Z Zhuang.   

Abstract

BACKGROUND: The histopathologic spectrum of colorectal neuroendocrine tumors ranges from benign to highly malignant. In this spectrum, poorly differentiated neuroendocrine carcinoma (PDNC) is the most aggressive type, characterized by early dissemination and a rapidly fatal course. Since it is unclear whether PDNC originates from neoplastic transformation of preexisting neuroectodermal cells, pluripotent epithelial stem cells, or adenocarcinoma precursor cells, we investigated the histogenesis of this type of cancer by performing genetic analyses on a series of colorectal tumors.
METHODS: Archived histologic sections of colorectal PDNC from nine patients were analyzed; gastrointestinal carcinoid tumor specimens from four patients were used as controls. The specimens were deparaffinized, microdissected, and analyzed genetically. After DNA extraction, polymerase chain reaction amplification was performed to investigate alteration (i.e., loss of heterozygosity [LOH]) of the APC (adenomatous polyposis coli), DCC (deleted in colorectal carcinoma), and p53 (also known as TP53) genes.
RESULTS: LOH of the APC, DCC, or p53 genes was observed in six of eight informative PDNC tumors; no LOH was detected in the carcinoid control specimens. Four of five informative PDNC tumors had associated adenocarcinoma; LOH of the APC and p53 genes in these tumors involved the same allele in both tissue components. Four of the five tumors with associated adenocarcinoma showed LOH of the DCC gene; in three of these four tumors, the PDNC and adenomatous components showed LOH of the same allele.
CONCLUSIONS: PDNC and associated adenocarcinoma appear to be derived from the same cell of origin, which is most likely either a pluripotent epithelial stem cell or an adenocarcinoma precursor cell.

Entities:  

Mesh:

Year:  1997        PMID: 9326914     DOI: 10.1093/jnci/89.19.1448

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  42 in total

Review 1.  Neuroendocrine differentiation: The mysterious fellow of colorectal cancer.

Authors:  Britta Kleist; Micaela Poetsch
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

2.  Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR.

Authors:  L Tauchmanovà; M Pensabene; I Capuano; I Spagnoletti; P Zeppa; S Del Vecchio; M Mainenti; G De Rosa; A Colao; A Contegiacomo
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

Review 3.  Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.

Authors:  Stefano La Rosa; Fausto Sessa; Silvia Uccella
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

4.  Early precursor of mixed endocrine-exocrine tumors of the gastrointestinal tract: histologic and molecular correlations.

Authors:  Fateh Bazerbachi; Taher R Kermanshahi; Carmela Monteiro
Journal:  Ochsner J       Date:  2015

5.  Large cell neuroendocrine carcinoma of the colon: A rare and aggressive tumor.

Authors:  Michael R Pascarella; David McCloskey; Jenia Jenab-Wolcott; Marc Vala; Marc Rovito; James McHugh
Journal:  J Gastrointest Oncol       Date:  2011-12

6.  Ampullary neuroendocrine tumor diagnosed by endoscopic papillectomy in previously confirmed ampullary adenoma.

Authors:  Seoung Ho Lee; Tae Hoon Lee; Si-Hyong Jang; Chi Young Choi; Won Myung Lee; Ji Hey Min; Hyun Deuk Cho; Sang-Heum Park
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

7.  In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components.

Authors:  Christine Woischke; Christian W Schaaf; Hui-Min Yang; Michael Vieth; Lothar Veits; Helene Geddert; Bruno Märkl; Peter Stömmer; David F Schaeffer; Matthias Frölich; Helmut Blum; Sebastian Vosberg; Philipp A Greif; Andreas Jung; Thomas Kirchner; David Horst
Journal:  Mod Pathol       Date:  2016-09-02       Impact factor: 7.842

Review 8.  On the Origin of Cells and Derivation of Thyroid Cancer: C Cell Story Revisited.

Authors:  Mikael Nilsson; Dillwyn Williams
Journal:  Eur Thyroid J       Date:  2016-06-24

Review 9.  Large cell neuroendocrine carcinoma of the ampulla of Vater with glandular differentiation.

Authors:  S-P Cheng; T-L Yang; K-M Chang; C-L Liu
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

Review 10.  Primary small cell neuroendocrine carcinoma of the kidney: morphological, immunohistochemical, ultrastructural, and cytogenetic study of a case and review of the literature.

Authors:  Stefano La Rosa; Barbara Bernasconi; Donata Micello; Giovanna Finzi; Carlo Capella
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.